Heghine Khachatryan/Linkedin
Aug 5, 2025, 02:28
Personalized Perioperative Management in Hemophilia: Key Insights from Heghine Khachatryan
Heghine Khachatryan, Head of Hemophilia and Thrombosis Center, Yeolyan Hematology and Oncology Center, recently shared a post on X:
“Individualized perioperative management based on FVIII/IX baseline levels and inhibitor status
•Algorithmic approach to factor replacement depending on BU levels and recovery response
•Adaptations for Emicizumab-treated patients and low-resource settings”
Stay informed with Hemostasis Today.
-
Apr 12, 2026, 12:04Riccardo Fumagalli: Long Term Complications Following Catheter Directed Thrombolysis in PE
-
Apr 12, 2026, 11:36Ifeanyichukwu Ifechidere: From Running Tests to Trusting Interpretation in Coagulation
-
Apr 12, 2026, 11:30Zack Rosanova: What Happens to Your Brain Without Sleep
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be